Dendritic cell vaccination

Review: dendritic cell-based vaccine in the treatment of patients with advanced melanoma

Melanoma-infiltrating dendritic cells induce protective antitumor responses mediated by T cells

Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma

Immunological response in the mouse melanoma model after local hyperthermia

Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes

Dendritic cell-based immunotherapy of malignant melanoma: success and limitations

Induction of dendritic cell-mediated immune responses against canine malignant melanoma cells

Results of a pilot trial of immunotherapy with dendritic cells pulsed with autologous tumor lysates in patients with advanced cancer

Lymphocyte subpopulations in melanoma patients treated with dendritic cell vaccines